Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-02-25 Purchase | 2026-02-27 08:33 am | LEXICON PHARMACEUTICALS INC. | LXRX | DEBBANE RAYMOND Director | 2,000 | $1.49 | $2,980 | 51,660,909 (Indirect Direct) | View |
| 2026-02-23 Purchase | 2026-02-25 07:00 am | LEXICON PHARMACEUTICALS INC. | LXRX | DEBBANE RAYMOND Director | 100,000 | $1.47 | $147,000 | 51,658,909 (Indirect Direct) | View |
| 2026-02-19 Purchase | 2026-02-23 07:49 am | LEXICON PHARMACEUTICALS INC. | LXRX | DEBBANE RAYMOND Director | 150,000 | $1.465 | $219,755 | 51,558,909 (Indirect Direct) | View |
| 2026-02-13 Purchase | 2026-02-18 4:30 pm | LEXICON PHARMACEUTICALS INC. | LXRX | DEBBANE RAYMOND Director | 268,497 | $1.3143 | $352,889 | 51,408,909 (Indirect Direct) | View |
| 2026-02-02 Purchase | 2026-02-04 4:25 pm | LEXICON PHARMACEUTICALS INC. | LXRX | Invus Global Management LLC Siren L.L.C. DEBBANE RAYMOND Artal Participations S.a r.l. Artal International S.C.A. Artal International Management S.A. Artal Group S.A. Westend S.A. Stichting Administratiekantoor Westend Director 10% Owner | 1,538,462 | $1.3 | $2,000,001 | 42,606,727 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-02-28 Tax Withholding | 2026-03-03 07:20 am | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | McDermott Wendy SVP, Human Resources | 68,107 | $1.47 | 619,049 (Direct) | View |
| 2026-02-28 Exercise | 2026-03-03 07:20 am | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | McDermott Wendy SVP, Human Resources | 224,406 | $0 | 619,049 (Direct) | View |
| 2026-02-28 Tax Withholding | 2026-03-03 07:20 am | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Martens Rachel Yap SVP, Partnerships & Corp Strat | 35,826 | $1.47 | 165,444 (Direct) | View |
| 2026-02-28 Exercise | 2026-03-03 07:20 am | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Martens Rachel Yap SVP, Partnerships & Corp Strat | 67,090 | $0 | 165,444 (Direct) | View |
| 2026-02-28 Tax Withholding | 2026-03-03 07:19 am | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Granowitz Craig B SVP, Chief Medical Officer | 109,098 | $1.47 | 802,177 (Direct) | View |
| 2026-02-28 Exercise | 2026-03-03 07:19 am | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Granowitz Craig B SVP, Chief Medical Officer | 312,276 | $0 | 802,177 (Direct) | View |
| 2026-02-28 Tax Withholding | 2026-03-03 07:18 am | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Gopinathan Suma SVP, Discovery | 24,338 | $1.47 | 301,722 (Direct) | View |
| 2026-02-28 Exercise | 2026-03-03 07:18 am | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Gopinathan Suma SVP, Discovery | 99,950 | $0 | 301,722 (Direct) | View |
| 2026-02-28 Tax Withholding | 2026-03-03 07:18 am | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | DeFrancesco Lisa SVP, IR and Corp Comm | 74,572 | $1.47 | 374,922 (Direct) | View |
| 2026-02-28 Exercise | 2026-03-03 07:18 am | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | DeFrancesco Lisa SVP, IR and Corp Comm | 152,864 | $0 | 374,922 (Direct) | View |
| 2026-02-28 Tax Withholding | 2026-03-03 07:17 am | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Crum Brian T SVP, General Counsel & Secr. | 105,019 | $1.47 | 838,516 (Direct) | View |
| 2026-02-28 Exercise | 2026-03-03 07:17 am | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Crum Brian T SVP, General Counsel & Secr. | 273,006 | $0 | 838,516 (Direct) | View |
| 2026-02-28 Tax Withholding | 2026-03-03 07:16 am | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Coiante Scott M SVP, Chief Financial Officer | 54,881 | $1.47 | 425,829 (Direct) | View |
| 2026-02-28 Exercise | 2026-03-03 07:16 am | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Coiante Scott M SVP, Chief Financial Officer | 160,237 | $0 | 425,829 (Direct) | View |
| 2026-02-28 Tax Withholding | 2026-03-03 07:15 am | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Exton Michael Chief Executive Officer | 204,831 | $1.47 | 1,304,959 (Direct) | View |
| 2026-02-28 Exercise | 2026-03-03 07:15 am | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Exton Michael Chief Executive Officer | 503,263 | $0 | 1,304,959 (Direct) | View |
| 2026-02-17 Option Award | 2026-02-19 4:50 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Artal Participations S.a r.l. Artal International S.C.A. Artal International Management S.A. Artal Group S.A. Westend S.A. Stichting Administratiekantoor Westend Wittouck Amaury Director 10% Owner | 41,290 | $65 | 408,435 (Indirect) | View |
| 2026-02-12 Option Award | 2026-02-17 4:10 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | McDermott Wendy SVP, Human Resources | 625,500 | $0 | 625,500 (Direct) | View |
| 2026-02-12 Option Award | 2026-02-17 4:10 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Martens Rachel Yap SVP, Partnerships & Corp Strat | 484,360 | $0 | 484,360 (Direct) | View |
| 2026-02-12 Option Award | 2026-02-17 4:09 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Granowitz Craig B SVP, Chief Medical Officer | 866,530 | $0 | 866,530 (Direct) | View |
| 2026-02-12 Option Award | 2026-02-17 4:08 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Gopinathan Suma SVP, Discovery | 596,130 | $0 | 596,130 (Direct) | View |
| 2026-02-12 Option Award | 2026-02-17 4:07 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | DeFrancesco Lisa SVP, IR and Corp Comm | 643,830 | $0 | 643,830 (Direct) | View |
| 2026-02-12 Option Award | 2026-02-17 4:07 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Crum Brian T SVP, General Counsel & Secr. | 749,270 | $0 | 749,270 (Direct) | View |
| 2026-02-12 Option Award | 2026-02-17 4:06 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Coiante Scott M SVP, Chief Financial Officer | 681,700 | $0 | 681,700 (Direct) | View |
| 2026-02-12 Option Award | 2026-02-17 4:05 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Exton Michael Chief Executive Officer | 2,156,110 | $0 | 2,156,110 (Direct) | View |
Ownership | 2026-02-12 9:29 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Avicenna Life Sci Master Fund LP Avicenna Life Sci Master GP LLC Director 10% Owner | 0 | $0 | 1,538,462 (Indirect) | View |
| 2026-02-02 Option Award | 2026-02-04 4:25 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Invus Global Management LLC Siren L.L.C. DEBBANE RAYMOND Artal Participations S.a r.l. Artal International S.C.A. Artal International Management S.A. Artal Group S.A. Westend S.A. Stichting Administratiekantoor Westend Director 10% Owner | 367,145 | $65 | 42,606,727 (Indirect) | View |
| 2026-02-02 Option Award | 2026-02-04 4:25 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Invus Global Management LLC Siren L.L.C. DEBBANE RAYMOND Artal Participations S.a r.l. Artal International S.C.A. Artal International Management S.A. Artal Group S.A. Westend S.A. Stichting Administratiekantoor Westend Director 10% Owner | 22,400,000 | $1.3 | 42,606,727 (Indirect) | View |
Ownership | 2025-06-09 10:03 am | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Gopinathan Suma SVP, Discovery | 0 | $0 | 637,980 (Direct) | View |
Ownership | 2025-06-06 5:40 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Martens Rachel Yap VP, Partnerships & Corp Strat | 0 | $0 | 553,346 (Direct) | View |
| 2025-06-03 Option Award | 2025-06-03 4:25 pm | N/A 2035-06-03 | LEXICON PHARMACEUTICALS INC. | LXRX | Swain Judith L Director | 193,118 | $0 | 193,118 (Direct) | View |
| 2025-06-03 Option Award | 2025-06-03 4:24 pm | N/A 2035-06-03 | LEXICON PHARMACEUTICALS INC. | LXRX | Sullivan Diane E. Director | 193,118 | $0 | 193,118 (Direct) | View |
| 2025-06-03 Option Award | 2025-06-03 4:23 pm | N/A 2035-06-03 | LEXICON PHARMACEUTICALS INC. | LXRX | SOBECKI CHRISTOPHER J Director | 193,118 | $0 | 193,118 (Direct) | View |
| 2025-06-03 Option Award | 2025-06-03 4:22 pm | N/A 2035-06-03 | LEXICON PHARMACEUTICALS INC. | LXRX | Cheung Ivan Director | 193,118 | $0 | 193,118 (Direct) | View |
| 2025-06-03 Option Award | 2025-06-03 4:22 pm | N/A 2035-06-03 | LEXICON PHARMACEUTICALS INC. | LXRX | BARKER SAM L Director | 193,118 | $0 | 193,118 (Direct) | View |
| 2025-06-03 Option Award | 2025-06-03 4:21 pm | N/A 2035-06-03 | LEXICON PHARMACEUTICALS INC. | LXRX | Amouyal Philippe Director | 193,118 | $0 | 193,118 (Direct) | View |
| 2025-06-03 Option Award | 2025-06-03 4:20 pm | N/A 2035-06-03 | LEXICON PHARMACEUTICALS INC. | LXRX | DEBBANE RAYMOND Director | 193,118 | $0 | 193,118 (Direct) | View |
| 2025-05-13 Exercise | 2025-05-13 5:52 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Swain Judith L Director | 36,810 | $0 | 85,174 (Direct) | View |
| 2025-05-13 Exercise | 2025-05-13 5:51 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Sullivan Diane E. Director | 36,810 | $0 | 36,810 (Direct) | View |
| 2025-05-13 Exercise | 2025-05-13 5:50 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | SOBECKI CHRISTOPHER J Director | 36,810 | $0 | 203,865 (Direct) | View |
| 2025-05-13 Exercise | 2025-05-13 5:50 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | BARKER SAM L Director | 36,810 | $0 | 124,459 (Direct) | View |
| 2025-05-13 Exercise | 2025-05-13 5:49 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Amouyal Philippe Director | 36,810 | $0 | 285,174 (Direct) | View |
| 2025-05-13 Exercise | 2025-05-13 5:48 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | DEBBANE RAYMOND Director | 36,810 | $0 | 45,755,796 (Direct) | View |
| 2025-02-28 Exercise | 2025-03-03 4:33 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Alexander Kristen VP, Finance and Accounting | 46,430 | $0 | 132,068 (Direct) | View |
| 2025-02-28 Tax Withholding | 2025-03-03 4:33 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Alexander Kristen VP, Finance and Accounting | 17,862 | $0.67 | 132,068 (Direct) | View |
| 2025-02-28 Exercise | 2025-03-03 4:33 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | McDermott Wendy SVP, Human Resources | 98,956 | $0 | 253,976 (Direct) | View |
| 2025-02-28 Tax Withholding | 2025-03-03 4:33 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | McDermott Wendy SVP, Human Resources | 30,004 | $0.67 | 253,976 (Direct) | View |